Drug Topics

AUGUST 10, 2023

A study published in the Lancet found that patients who had previously tested positive for COVID-19 had lower cognitive accuracy compared to negative controls.

187

187

Pharmacy Times

AUGUST 10, 2023

There was no association between the amount of evidence behind a product and the time until Medicare coverage, suggesting issues within the coverage determination process itself.

FDA 122

FDA 122

Drug Topics

AUGUST 10, 2023

After sessions end, head out to explore the city of San Diego.

187

187

Pharmacy Times

AUGUST 10, 2023

Results of phase 3 trials could lead to the approval of remibrutinib to provide more effective and controlled treatment of chronic spontaneous urticaria than H1-antihistamines.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

AUGUST 10, 2023

Results from a recent study indicated that lowering the threshold for abnormal blood pressure in the second half of pregnancy from 140/90 mm Hg would not increase accuracy in identifying maternal or perinatal risk in patients.

98

98

Pharmacy Times

AUGUST 10, 2023

Approximately 57% of individuals who were shown a flowchart of the FDA vaccine approval process were very or somewhat likely to recommend a respiratory syncytial virus vaccine to a pregnant family member or friend compared to only 40% of those who were not shown the process.

Vaccines 122

Vaccines Communication FDA 122

Pharmacy Times

AUGUST 10, 2023

Policy efforts must be put in place to support HCV treatment for all individuals to reduce the disparities in direct-acting antiviral treatment.

123

123

Drug Topics

AUGUST 10, 2023

From outreach programs to point-of-care testing—and a solid online presence—here are a few ways to stand out from the crowd.

98

98

Pharmacy Times

AUGUST 10, 2023

Findings may have therapeutic implications because of the potential to target neurotransmitters to treat or prevent melanoma.

Communication 123

Communication 123

Board Vitals - Pharmacist

AUGUST 10, 2023

The journey to becoming a certified surgical technologist is a noble one, filled with dedication, perseverance, and a commitment to excellence. At the heart of this journey lies a crucial milestone – the NBSTSA Surgical Technology Exam. This comprehensive exam contains 175 questions (150 graded) with a pass rate of just 73.7% in 2020. How can you best prepare for the CST exam ?

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

AUGUST 10, 2023

After Pfizer allegedly fired a compliance manager for raising the flag on potential fraud activity in China, the former employee is hitting back. | Frank Han, Pfizer's former director of global compliance analytics, has filed a civil complaint against the drugmaker. Han claims he was terminated for identifying potential issues relating to the Foreign Corrupt Practices Act.

98

98

Fierce Healthcare

AUGUST 10, 2023

Medicare Part D drug prices have increased by an average of 226% since market entry. These 25 drugs are responsible for $80.9 billion in total Part D spending in 2021. | A report from AARP broke down how popular brand-name drugs have continued to rise in price and exceed inflation.

98

98

STAT

AUGUST 10, 2023

Dan Worthley, a gastroenterologist and cancer scientist at Colonoscopy Clinic in Brisbane, Australia, does thousands of colonoscopies a year, seeking and destroying precancerous polyps. It’s a practically surefire way to prevent colorectal cancer, but an unpleasant experience for patients. The future, Worthley hopes, will be much less onerous — and he’s developing a technology that, if it works one day, might make the experience more of a piece of cake.

98

98

Fierce Healthcare

AUGUST 10, 2023

Mantra Health, a digital mental health provider for higher education, is joining forces with adolescent-focused Charlie Health to broaden access for students seeking higher levels of care. | The partners will connect college and university students who require a higher level of mental health care to Charlie Health’s virtual intensive outpatient program.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

AUGUST 10, 2023

Carol Spence’s vision is flooded with green. As her brush swoops right and swishes left, she’s first transported to a lush spring meadow, then to the canopies of a rainforest — every stroke bringing her to another verdant utopia. Until she hears her daughter scream, “What are you doing?!

98

98

Fierce Healthcare

AUGUST 10, 2023

4 in 5 health plan execs are significantly concerned about rising GLP-1 utilization and costs, according to a newly | 4 in 5 health plan execs are significantly concerned about rising GLP-1 utilization and costs, according to a newly released survey from Virta Health.

98

98

STAT

AUGUST 10, 2023

As a new class of obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for nearly half of the patients with insurance claims for GLP-1 prescriptions in 2022.

Insurance 98

Insurance 98

Fierce Pharma

AUGUST 10, 2023

Johnson & Johnson is digging its multiple myeloma moat deeper thanks to FDA approval for another novel drug. | Johnson & Johnson is digging its multiple myeloma moat deeper. The FDA has signed off on the company's Talvey, a first-in-class bispecific antibody targeting GPRC5D.

FDA 98

FDA 98

STAT

AUGUST 10, 2023

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome. What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December , Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were

98

98

Fierce Healthcare

AUGUST 10, 2023

Sutter Health logged a $29 million operating income (0.8% operating margin) and $265 million bottom line for the quarter ended June 30, thanks in part to higher patient volumes and their accompanyi | The California nonprofit system's 0.8% operating margin and $265 million net income are clear improvements over the previous year's performance.

98

98

STAT

AUGUST 10, 2023

As demand for Ozempic and Wegovy surges, a little-noticed warning about the medicines was issued recently by regulators. In late May, the Food and Drug Administration said it received a “few” adverse event reports concerning compounded versions of the injectable medicines, which both contain the same active ingredient, known as semaglutide.

Compounding 98

Compounding 98

Fierce Pharma

AUGUST 10, 2023

As Regeneron anxiously awaits an FDA decision on a high-dose version of Eylea (aflibercept), the company has continually referred to its durability compared to that of Roche’s upstart Vabysmos—whic | As Regeneron anxiously awaits an FDA decision on a high-dose version of Eylea (aflibercept), the company has continually referred to its staying power compared to that of Roche’s upstart Vabysmos—which has taken the macular degeneration (AMD) market by storm since receiving approval 19 months ago.

FDA 98

FDA 98

STAT

AUGUST 10, 2023

ST. LOUIS — Firefighter and paramedic Mike Camilleri once had no trouble hauling heavy gear up ladders. Now battling long Covid, he gingerly steps onto a treadmill to learn how his heart handles a simple walk. “This is, like, not a tough-guy test so don’t fake it,” warned Beth Hughes, a physical therapist at Washington University in St.

98

98

BioPharm

AUGUST 10, 2023

The site was acquired by AGC Biologics in July 2020, and the Milan location is the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supplies.

98

98

STAT

AUGUST 10, 2023

Fresh off of the news that its drug Wegovy may not just help people lose weight, but could also lower cardiac risks , Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a small Canadian biotech with a new approach to weight loss. Novo will spend up to $1 billion to buy Inversago Pharma, which is developing an oral obesity drug that targets the cannabinoid receptor CB1.

98

98

European Pharmaceutical Review

AUGUST 10, 2023

The US Food and Drug Administration (FDA) has granted accelerated approval of TALVEY (talquetamab-tgvs) to treat multiple myeloma. Janssen Pharmaceutical Companies of Johnson & Johnson’s first-in-class bispecific T-cell engaging antibody showed an overall response rate (ORR) of over 70 percent in heavily pre-treated multiple myeloma. Based on this data, TALVEY is indicated for adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, includin

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

STAT

AUGUST 10, 2023

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%. But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to the “overwhelming demand for Wegovy.

98

98

Fierce Pharma

AUGUST 10, 2023

In this episode of "The Top Line," Teresa Carey talks with Dr. | This week on "The Top Line," we discuss left-handedness and its significance in neurodevelopmental and psychiatric disorder research.

98

98

STAT

AUGUST 10, 2023

AdventHealth, a large religious-affiliated hospital system, has sued MultiPlan, alleging the company has worked with health insurers to create a “cartel” that systematically underpays hospitals and doctors for care that is delivered out of an insurance company’s network. AdventHealth claims it has “overwhelming direct evidence” that MultiPlan’s agreements with health insurance companies are anticompetitive, and that MultiPlan’s “multi-year,

Health Insurance Companies 97

Health Insurance Companies Insurance Hospitals 97

PharmExec

AUGUST 10, 2023

Hernandez details how the non-profit organization advocates for improved access to care at the community, state, and federal levels, and amplifies education and awareness efforts within its social media communities.

98

98

STAT

AUGUST 10, 2023

Following an extensive inspection, the Environmental Protection Agency fined Genentech more than $158,000 for hazardous waste violations at a facility in California, the latest instance in which a pharmaceutical company has been cited for failing to adhere to environment regulations. The inspection took place at three locations around a South San Francisco site run by the company, which is a unit of Roche.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies 97

PharmExec

AUGUST 10, 2023

The application of artificial intelligence is steadily finding a home in the pharma industry, but these tools may have unprecedented potential in a more nascent niche along the life sciences continuum: drug development.

98

98

The Checkup by Singlecare

AUGUST 10, 2023

Not only are dogs man’s best friends, but our fur babies also become honorary family members. We would do anything for them, but sometimes it’s hard to know what’s wrong when they’re feeling down. Since our dogs can’t communicate when they have loose stool or bouts of diarrhea , how do we know if it’s something we should be concerned about? We went to the veterinarian medical experts to find out.

Communication 98

Communication Immunization Hospitals 98

The Honest Apothecary

AUGUST 10, 2023

Have you ever asked yourself this question: “What is the next step in my leadership journey?” It is a good question. Leadership is like climbing a mountain that has no pea or a ladder that has no top rung. Real leaders are generally hungry for the next challenge. They take a tough opportunity, give it their best, then start looking for the next giant to go after.

98

98